Exagen Inc. To Participate in 2021 ICR Conference
05 janv. 2021 16h05 HE
|
Exagen Inc.
SAN DIEGO, Jan. 05, 2021 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), an organization dedicated to transforming the care continuum for patients suffering from autoimmune diseases, announced today...
Exagen Inc. Partners with Oregon’s St. Charles Health System to Offer AVISE® Testing as an In-Network Benefit for Patients Suffering from Debilitating Autoimmune Diseases
04 janv. 2021 16h05 HE
|
Exagen Inc.
SAN DIEGO, Jan. 04, 2021 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), an organization dedicated to transforming the care continuum for patients suffering from autoimmune diseases, announced today...
Exagen Inc. to Participate in December Investor Conferences
18 nov. 2020 16h05 HE
|
Exagen Inc.
SAN DIEGO, Nov. 18, 2020 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), an organization dedicated to transforming the care continuum for patients suffering from autoimmune diseases, announced today...
Exagen and GSK partner for 4th straight year, driving greater awareness of challenges facing lupus diagnosis and management
16 nov. 2020 08h25 HE
|
Exagen Inc.
SAN DIEGO, Nov. 16, 2020 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), an organization dedicated to transforming the care continuum for patients suffering from debilitating and chronic autoimmune...
Exagen Inc. Reports Third Quarter 2020 Results
10 nov. 2020 16h05 HE
|
Exagen Inc.
SAN DIEGO, Nov. 10, 2020 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), an organization dedicated to transforming the care continuum for patients suffering from autoimmune diseases, today reported...
Exagen Inc. To Participate in November Investor Conferences
09 nov. 2020 08h25 HE
|
Exagen Inc.
SAN DIEGO, Nov. 09, 2020 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), an organization dedicated to transforming the care continuum for patients suffering from autoimmune diseases, announced today...
Exagen Inc. Announces Study to Evaluate Emergence of Autoimmune Diseases After COVID-19 Infection
02 nov. 2020 08h25 HE
|
Exagen Inc.
SAN DIEGO, Nov. 02, 2020 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), an organization dedicated to transforming the care continuum for patients suffering from autoimmune diseases, announced today...
Exagen to Announce Third Quarter Financial Results on November 10, 2020
27 oct. 2020 16h05 HE
|
Exagen Inc.
SAN DIEGO, Oct. 27, 2020 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), an organization dedicated to transforming the care continuum for patients suffering from autoimmune diseases, today announced...
Exagen Showcases Six Scientific Presentations at ACR’s First Virtual Annual Meeting in November 2020
21 oct. 2020 16h05 HE
|
Exagen Inc.
SAN DIEGO, Oct. 21, 2020 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), an organization dedicated to transforming the care continuum for patients suffering from autoimmune diseases, announced...
New Data Demonstrates Economic Benefit of Exagen’s AVISE® Lupus Test for Payors
12 oct. 2020 16h05 HE
|
Exagen Inc.
SAN DIEGO, Oct. 12, 2020 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), an organization dedicated to transforming the care continuum for patients suffering from autoimmune diseases, today announced...